<DOC>
	<DOCNO>NCT02970929</DOCNO>
	<brief_summary>An extension study safety tolerability SEP-363856 adult subject schizophrenia</brief_summary>
	<brief_title>An Extension Study Safety Tolerability SEP-363856 Adult Subjects With Schizophrenia</brief_title>
	<detailed_description>This 26 week , multiregional , open-label extension study design evaluate long-term safety tolerability SEP-363856 treatment subject schizophrenia complete 4 week double-blind treatment phase Study SEP361-201 . No statistical hypothesis test perform .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Subject must give write informed consent privacy authorization prior participation study able comply protocol , opinion investigator . Subject complete Study SEP361 201 Week 4 Subject take medication study drug purpose control schizophrenia symptom Study SEP361 201 . Female subject must negative urine pregnancy test Visit 7 Study SEP361 201 ; female postmenopausal ( define least 12 month spontaneous amenorrhea ) undergone hysterectomy bilateral oophorectomy exempt pregnancy test . Male subject female partner ( ) childbearing potential must agree avoid father child use acceptable method birth control screen least 30 day last study drug administration Subject answer `` yes '' `` suicidal ideation '' Item 4 ( active suicidal ideation intent act , without specific plan ) Item 5 ( active suicidal ideation specific plan intent ) CSSRS assessment Visit 7 Study SEP361 201 . Subjects answer `` yes '' question must refer Investigator follow evaluation . Subject clinically significant abnormality include physical examination , vital sign , ECG , laboratory test Visit 7 Study SEP361 201 investigator consultation medical monitor considers inappropriate allow participation study . Subject positive urine drug screen ( UDS ) breath alcohol test Visit 7 Study SEP361 201 . Subject pregnant lactating . Subject high risk noncompliance Investigator 's opinion . Subject opinion Investigator , unsuitable way participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>